FDA Inspection 1163548 - Dhaliwal Pharmaceuticals Laboratories, LLC - March 01, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Dhaliwal Pharmaceuticals Laboratories, LLC, with an inspection on March 1, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Dhaliwal Pharmaceuticals Laboratories, LLC
Inspection Date: March 1, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 617782f6-6384-43ab-bb87-24cd1361681d

Violation Codes1

21 CFR 211.100(b)

Full citation text and observation details available on the Dashboard.